The drug treatment strategy also involved with selecting drugs like thrombolytics anticoagulants, antihypertensives (angiotensin converting enzyme-inhibiters, angiotensin II receptor blockers, and diuretics), blood lipid lowering agents (statins), antiplatelet drugs (aspirin and clopidogrel), and cerebral activators. It is also recommended to select, a route, and dosage form of drugs to have optimal therapeutic effects to manage Cerebrovascular Accident.
 In the present study, we found that 77 (75.49%) patients were administered cerebral activators. The preferred cerebral activator was Piracetam, which was administered to 49 (48.03%) stroke patients, this was followed by Nimodipine 10 (9.8%), and few patients were simultaneously co-administered both, Piracetam and Nimodipine 18 (17.64%).
The complete study shows that the uses of medication in stroke are cerebral activators as Piracetam and Nimodipine.